SPDL1 and neoplasm: Furthermore, sPDL1 could contribute to the immune evasion mechanism, treatment resistance, and worse prognosis as well as sTIM3 values below the median (7972 pg/ml), reflecting the role attributed to their transmembrane form when expressed by tumor cells (18, 28–37).